Clinical Trials on Advanced Solid Tumor Malignancies

Total 10 results

  • NCT04094506
    Active, not recruiting
    Conditions: Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
  • NCT02934568
    Recruiting
    Conditions: Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies
  • NCT04537715
    Recruiting
    Conditions: All Malignancies, Advanced Malignancies, Hematologic Malignancy, Solid Tumor, Follicular Lymphoma (FL), Non-Hodgkin Lymphoma (NHL), Diffuse Large B-Cell Lymphoma (DLBCL), Epithelioid Sarcoma (ES), Synovial Sarcoma, Renal Medullary Carcinoma, Mesothelioma, Rhabdoid Tumor
  • NCT02000934
    Active, not recruiting
    Conditions: Advanced Solid Tumor and Lymphoma Malignancies
  • NCT03297424
    Recruiting
    Conditions: Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma, Non-Hodgkin Lymphoma, Advanced Malignancies, Solid Tumor, Diffuse Large B Cell Lymphoma, Follicular Lymphoma
  • NCT03199586
    Completed
    Conditions: Breast Cancer, Pancreas Cancer, Prostate Cancer, Lung Cancer, Colon Cancer, Esophagus Cancer, Liver Cancer, Ovary Cancer, Advanced or Metastatic Treatment-refractory Solid Tumor Malignancies
  • NCT02298387
    Completed
    Conditions: Advanced Solid Tumor Malignancies
  • NCT01522989
    Active, not recruiting
    Conditions: Advanced Solid Tumor Malignancies
  • NCT01284192
    Completed
    Conditions: Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS, Solid Tumor, B-Cell Lymphoma
  • NCT00996515
    Completed
    Conditions: Advanced Solid Tumor Malignancies